Embecta Corp. Announces FDA Clearance Of Its Disposable Insulin Delivery System

(RTTNews) - Embecta Corp. (EMBC) has received 510(k) clearance from the FDA for its disposable insulin delivery system. Indicated for adults who require insulin to manage diabetes, including both type 1 and type 2, the system includes a tubeless patch pump design with a 300-unit insulin reservoir.

The system includes a wearable, fully disposable patch pump that provides adjustable basal and bolus insulin for up to three days. Also, the system comprises a locked-down controller featuring Bluetooth wireless technology with a color touchscreen designed to create a simplified interface and user experience.

For More Such Health News, visit rttnews.com.